Southwestern Clinical Pharmacy Seminar

APRIL 27-29, 2018

This 1.5 day seminar provides approximately eleven (11) hours of continuing education, and networking opportunities for pharmacy professionals focusing on clinical topics pertinent to institutional and ambulatory care practice settings.


JUNE 14-17, 2018


This four-day annual conference provides over fifteen (15) hours of continuing education, recognition, and networking opportunities for pharmacy professionals of all practice settings.

Southwestern States Residency Conference

JUNE 15th

Join over 150 Residents and Preceptors at this annual event where residents get the opportunity to present their Residency Research Projects.

AzPA Immunization Certificate Program

APRIL 14TH | JUNE 14th

This program is an interactive educational program that provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education, and administration.

Pain Management Certificate Program

JULY 28TH 2018

Featuring a new kind of Certificate Program! This entire learning experience can be done in the comfort of your own home. It consists of a Home Study Component and a Live Webinar - That's it!


Learn with us


Discover your voice


Get involved! Serve on a team

RSS AzPA Pharmacy Flash

  • Will CVS's new Rx Savings Finder help reduce costs?
    After working nearly 25 years in retail and about seven years doing in-depth formulary analysis, I've learned one about prescription insurance: copays are confusing. CVS pharmacy hopes to reduce this confusion by introducing a new "Rx Savings Finder" tool to help pharmacists help their patients find a better deal. As optimistic as I want to […]
  • Pharmacies can administer vaccines at a lower cost than doctor's offices and medical clinics, study shows
    Providers and patients alike could stand to save time and money if federal law is reformed to allow pharmacists to administer all vaccines recommended by the Centers for Disease Control and Prevention, a new study released by the Pacific Research Institute found.
  • Rigel secures FDA approval for rare disease drug
    The Food and Drug Administration recently approved Rigel Pharmaceutical Inc.'s Tavalisse, an oral spleen tyrosine kinase inhibitor designed to prevent autoimmune attacks in chronic immune thrombocytopenia.

Upcoming Events

Upcoming Events

Southwestern Clinical Pharmacy Seminar

04/27/2018 - 04/29/2018


AzPA Annual Convention

06/14/2018 - 06/17/2018

Sheraton Grand at Wild Horse Pass

Annual Convention Exhibitor Registration

06/15/2018 - 06/17/2018

Sheraton Grand at Wild Horse Pass